A simple urine test can more than halve the number of cystoscopies necessary to follow up high-risk bladder cancer patients, new research has found. Cystoscopies involve inserting a flexible probe ...
A simple urine test can more than halve the number of cystoscopies necessary to follow up high-risk bladder cancer patients, new research has found. Cystoscopies involve inserting a flexible probe ...
A new urine test could spare bladder cancer survivors from a painful follow-up procedure needed to ensure their cancer hasn't come back, researchers report. People who've gotten surgery for high-risk ...
March 10 (UPI) --Identifying genetic mutations in urine could help detect bladder cancer years before symptoms arise, a new study presented Friday at the European Association of Urology annual ...
Add Yahoo as a preferred source to see more of our stories on Google. A range of other assessments besides the bladder pressure test work just as well in guiding treatment of female incontinence, ...
Results of the European multi-center study of Bladder EpiCheck ™ urine test, supporting reduction of invasive procedures, were published in the European Urology Oncology journal Nucleix Ltd., a ...
Bladder cancer has a five-year survival rate of over 80% when detected early, but this rate declines significantly as the disease progresses to advanced stages. In a novel study in The Journal of ...
Bright Uro Inc. this month received Food and Drug Administration approval for its first product, the Glean Urodynamics System. It’s the biggest milestone to date for the Irvine medical device maker ...
BIRMINGHAM, England--(BUSINESS WIRE)--Nonacus, a provider of genetic testing products for precision medicine and liquid biopsy, and the University of Birmingham have partnered to develop a ...
A urine test was shown to decrease the need for invasive cystoscopies in patients with non-muscle-invasive bladder cancer. A urine-based test may decrease the number of invasive cystoscopies in ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc., (Nasdaq: VCYT) announced today the publication of new data demonstrating that the company’s Decipher Bladder genomic classifier accurately ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results